SearchDictionaryMobileLogin

Particulate Matter

594  relevant articles (7 outcomes, 82 trials/studies) found for this Bio-Agent

Description: Particles of any solid substance, generally under 30 microns in size, often noted as PM30. There is special concern with PM1 which can get down to PULMONARY ALVEOLI and induce MACROPHAGE ACTIVATION and PHAGOCYTOSIS leading to FOREIGN BODY REACTION and LUNG DISEASES.

Also Known As:
Air Pollutants, Particulate; Airborne Particulate Matter; Ambient Particulate Matter; Particulate Air Pollutants; Particulate Matter, Airborne; Particulate Matter, Ambient; Pollutants, Particulate Air

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kaufman, J: 4 articles (08/2008 - 12/2000)
2. Borm, Paul J A: 4 articles (08/2006 - 05/2002)
3. Nel, Andre E: 3 articles (05/2008 - 12/2003)
4. Cassee, Flemming R: 3 articles (08/2006 - 10/2002)
5. Schins, Roel P F: 3 articles (05/2006 - 05/2002)
6. Auchincloss, A H: 2 articles (08/2008 - 09/2006)
7. Jacobs, D R: 2 articles (08/2008 - 09/2006)
8. van Eeden, Stephan F: 2 articles (07/2008 - 01/2005)
9. Li, Ning: 2 articles (05/2008 - 12/2003)
10. Xia, Tian: 2 articles (05/2008 - 01/2007)

Related Diseases

1. Infection
09/01/1977 - "Tentative conclusions concerning the role of recognition and ingestion of microorganisms by phagocytes in host defense and the consequences of disorders of phagocytosis can be derived by correlating a) knowledge about recognition and ingestion derived from studies in vitro, b) investigations of the clearance of particulate matter from the circulation of animals and man, and c) analyses of the behavior of phagocytes in patients susceptible to recurrent pyogenic infections. "
01/01/2006 - "This has been attributed to its complex anatomy and prominent reticuloendothelial functions which include clearance of unwanted particulate matter in blood ( culling), defense against infection and reservoir for blood cells. "
10/01/2002 - "This laboratory has previously demonstrated that a single inhalation exposure of Streptococcus pneumoniae-infected rats to concentrated ambient PM(2.5) (particulate matter with aerodynamic diameter < or =2.5 microm) from New York City (NYC) air exacerbates the infection process and alters pulmonary and systemic immunity. "
05/01/2001 - "At the same time the accumulation of viruses on suspended particulate matter increases the likelihood of an infection after incorporation of such a particle. "
10/01/2000 - "CONCLUSIONS: There are functional lymphatico-venous communications at the very peripheral level under physiological conditions, which allow rapid transport of viral-size particulate matter between the two pathways and may contribute to the spread of viral infection."
Order ALL the reference details at left...
2. Wounds and Injuries (Trauma)
3. Sepsis (Septicemia)
4. Lacerations
5. Tuberculosis

Related Drugs and Biologics

1. Fibrin
2. Ozone
3. Carbon Monoxide
4. Nitrogen Dioxide
5. Air Pollutants (Pollutants, Air)
6. Sulfur Dioxide
7. Particulate Matter
8. Smoke
9. Nitrogen Oxides
10. 1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)

Related Therapies and Procedures

1. Debridement
2. Prostheses and Implants (Prosthesis)
3. Nutritional Support (Artificial Feeding)
4. Splenectomy
5. Radial Keratotomy

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 14726 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>